Related references
Note: Only part of the references are listed.Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava et al.
MOLECULAR PSYCHIATRY (2020)
Ketamine facilitates extinction of avoidance behavior and enhances synaptic plasticity in a rat model of anxiety vulnerability: Implications for the pathophysiology and treatment of anxiety disorders
Ashley M. Fortress et al.
NEUROPHARMACOLOGY (2018)
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Gerard Sanacora et al.
JAMA PSYCHIATRY (2017)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
A single infusion of ketamine improves depression scores in patients with anxious bipolar depression
Dawn F. Ionescu et al.
BIPOLAR DISORDERS (2015)
Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine
Dawn F. Ionescu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Repeated Ketamine Exposure Induces an Enduring Resilient Phenotype in Adolescent and Adult Rats
Eric M. Parise et al.
BIOLOGICAL PSYCHIATRY (2013)
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: A report of OPERATION study
Zhiguo Wu et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Severe and anxious depression: Combining definitions of clinical sub-types to identify patients differentially responsive to selective serotonin reuptake inhibitors
George H. Papakostas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report
Herng Nieng Chan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Assessing anxious features in depressed outpatients
Shawn M. McClintock et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2011)
Distinctive Clinical Characteristics and Suicidal Tendencies of Patients With Anxious Depression
Ho-Jun Seo et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2011)
Prevalence and Treatment Outcome in Anxious Versus Nonanxious Depression: Results From the German Algorithm Project
Katja Wiethoff et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
ANXIOLYTIC- AND ANTI DEPRESSANT-LIKE PROPERTIES OF KETAMINE IN BEHAVIORAL AND NEUROPHYSIOLOGICAL ANIMAL MODELS
E. Engin et al.
NEUROSCIENCE (2009)
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report
Maurizio Fava et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder
George I. Papakostas et al.
PSYCHIATRY RESEARCH (2008)
Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study
Daniel Souery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D
M Fava et al.
PSYCHOLOGICAL MEDICINE (2004)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
